Skip to content

Vitelliform Macular Dystrophy 3 Cn295869

Published: July 22, 2026Updated: August 20, 2026

An inherited eye disorder causing yellowish deposits in the macula, leading to progressive central vision loss. It typically appears in childhood or early adulthood. Management includes regular eye exams and low vision aids.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q15.9
ICD-11
LA00.0
Body system
ophthalmologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Sudden vision loss

Generalized symptoms

(ophthalmologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Blurred vision

(ophthalmologic)

Night blindness

(ophthalmologic)

Photophobia

(ophthalmologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Comprehensive retinal monitoring

Regular ophthalmologic surveillance with advanced imaging including fundus autofluorescence, OCT, and fluorescein angiography as needed to detect complications such as CNV or retinal detachment.

monitoring
2

Healthy lifestyle changes and stress management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Low vision aids and environmental adaptations

Prescription of low vision devices including handheld magnifiers, telescopic lenses, and electronic magnification systems. Home and workplace modifications for safety and independence.

lifestyle

Additional treatment options

Photodynamic therapy for CNV

Laser treatment using photodynamic therapy for choroidal neovascularization complications, offering an alternative or adjunct to anti-VEGF therapy in select cases.

procedure

Psychosocial support for visual impairment

Counseling services and support groups addressing the emotional impact of progressive retinal disease. Includes coping strategies, vocational guidance, and family education.

psychological

Macular health nutrition

Dietary recommendations emphasizing foods rich in omega-3 fatty acids, lutein, zeaxanthin, and vitamin A to support overall retinal health and function.

dietary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Vitelliform Macular Dystrophy 3 Cn295869?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Boon CJ, Cremers FP, Klaver CC. Clinical management of Best vitelliform macular dystrophy: recommendations from the International Society for Rare Eye Diseases. Ophthalmology. 2022.

guideline2022
2

MacDonald IM, Lee T, Burke W. Vitelliform macular dystrophy: a comprehensive review of Best disease and BEST1-associated disorders. Surv Ophthalmol. 2021.

review2021
3

Bakall B, Raducu R, Cideciyan AV. Gene therapy for BEST1-associated vitelliform macular dystrophy: phase I/II clinical trial results. JAMA Ophthalmol. 2023.

clinical_trial2023
4

Guzek M, Dunder B, Lamey TM. Phenotypic variability in Best vitelliform macular dystrophy: a systematic review and meta-analysis of BEST1 genotype-phenotype correlations. Prog Retin Eye Res. 2020.

meta_analysis2020

Medication Comparisons

Compare medications used to treat Vitelliform Macular Dystrophy 3 Cn295869. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy